
Telkris AMH 40mg/5mg/12.5mg Tablet
Marketer
Krishbaj India Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telkris AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Valsartan 40mg/5mg/12.5mg tablets (a triple-combination therapy) manage hypertension when single-agent treatment proves insufficient. This medication lowers elevated blood pressure, mitigating the risk of stroke and heart attack. Take this medication with or without food, at the same time daily, as directed by your physician. Continue taking it as prescribed; discontinuation increases stroke/heart attack risk. Because it includes a diuretic, increasing urination, avoid taking it within four hours of bedtime. Consistent use maximizes its effectiveness, even if feeling well (high blood pressure often lacks symptoms). Common side effects include headache, dizziness, fatigue, altered taste, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counter potential muscle weakness, dry mouth, or thirst. Prior to initiating treatment, inform your doctor of any kidney or liver conditions, pregnancy, breastfeeding, or other medications you are taking, especially those for hypertension or heart disease. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to assess treatment efficacy.
Primary Ingredients of Telkris AMH 40mg/5mg/12.5mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Telkris AMH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telkris AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Telkris AMH 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Telkris AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telkris AMH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telkris AMH 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistency in timing is recommended.
How Telkris AMH 40mg/5mg/12.5mg Tablet works:
Combining telmisartan, amlodipine, and hydrochlorothiazide, Telkris AMH 40mg/5mg/12.5mg tablets offer a three-drug approach to blood pressure management. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing vascular resistance and lowering blood pressure. Hydrochlorothiazide, a diuretic, facilitates fluid excretion, contributing to blood pressure reduction through diuresis and, in the long term, also by promoting vasodilation and improved circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telkris AMH 40mg/5mg/12.5mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Telkris AMH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated except in rare, life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administration of Telkris AMH 40mg/5mg/12.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telkris AMH 40mg/5mg/12.5mg Tablets. These tablets can induce dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telkris AMH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. Telkris AMH 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Telkris AMH 40mg/5mg/12.5mg Tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Telkris AMH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Telkris AMH 40mg/5mg/12.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telkris AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
